Pathological evaluation of tumor infiltrating lymphocytes and the benefit of nivolumab in advanced non-small cell lung cancer (NSCLC) I. Gataa,L. Mezquita,E. Auclin,S. Le Moulec, P. Alemany, M. Kossai,J. Massé, C. CARAMELLA,J. Remon Masip,J. Lahmar,R. Ferrara,A. Gazzah,J-C. Soria,D. Planchard,B. Besse,J. AdamANNALS OF ONCOLOGY(2017)引用 4|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要